Nirsevimab for Respiratory Syncytial Virus Prophylaxis in Newborns and Infants

NEJM Evid. 2025 Mar;4(3):EVIDe2400440. doi: 10.1056/EVIDe2400440. Epub 2025 Feb 25.

NO ABSTRACT

PMID:39998304 | DOI:10.1056/EVIDe2400440